Search Results (516)

Natural compounds such as polyphenols, flavonoids, and terpenoids have long been explored for their therapeutic potential. They can act as antioxidants, limit inflammation, and influence cancer or neurodegenerative pathways. However, these benefits rarely translate directly into medical practice, as their solubility is poor, chemical stability is fragile, and metabolism is too fast. In recent years, nanotechnology has offered an alternative route. A wide range of materials, polymeric, inorganic, hybrid, or responsive to external stimuli, were designed to protect and deliver such molecules. Each platform features different preparation methods and release behaviors; all intended to extend circulation and increase tissue selectivity. Considerable attention was paid to targeting strategies, both passive and ligand-mediated, that enhance accumulation in diseased tissues. Preclinical studies have confirmed that encapsulation can raise the therapeutic index of phytochemicals against various conditions, including cancer, inflammation, microbial infections, and neurodegeneration. Still, translation to the clinic is far from resolved, limited by uncertainties over safety, manufacturing scale, and regulation. A parallel line of research now investigates biomimetic carriers, including vesicles derived from red blood cells and whole erythrocytes, which offer immune evasion and versatile loading capacity. The convergence of nanotechnology and natural product pharmacology, enriched by such biologically inspired designs, may open the way to more precise, multifunctional, and patient-tailored therapies. Full article

Glioblastoma (GB) is one of the most aggressive and treatment-resistant cancers affecting the central nervous system (CNS), predominantly in adults. Despite significant advancements in this field, GB treatment still relies primarily on conventional approaches, including surgical resection, radiotherapy, and chemotherapy, which, due to its complex pathological characteristics, resistance mechanisms, and restrictive nature of the blood–brain barrier (BBB) and blood–brain tumor barrier (BBTB), remain of limited efficacy. In this context, the development of innovative therapeutic strategies able to overcome these barriers, induce cancer cell death, and improve patient prognosis is crucial. Recently, nanoparticle platforms and focused ultrasounds seem to be promising approaches for cancer treatment. Nanoparticles enable targeting and controlled release, whilst focused ultrasounds enhance tissue permeation, increasing drug accumulation in a specific organ. However, nanoparticles can suffer from synthesis complexity, long-term biocompatibility and accumulation in the body with consequent toxicity, whereas focused ultrasounds require specialized equipment and can potentially cause thermal damage, hemorrhage, or cavitation injury. Cyclodextrins (CYDs) possess good properties and represent a versatile and safer alternative able to improve drug stability, solubility, and bioavailability, and depending on the type, dose, and administration route, can reduce local and systemic toxicity. Thus, CYDs emerge as promising novel excipients in GB treatment. Despite these advantages, CYD complexes suffer from receptor specificity, reducing their potential in precision medicine. By combining CYD complexes with polymeric or lipidic platforms, the advantages of CYD safety and drug solubilization together with their specific targeting can be obtained, thus enhancing selectivity and maximizing efficacy while minimizing recurrence and systemic toxicity. This review provides a comprehensive overview of GB pathology, conventional treatments, and emerging CYD-based strategies aimed at enhancing drug delivery and therapeutic efficacy. Full article

The versatility of emulsions as templates for fabricating functional materials has garnered significant attention in recent decades. Emulsions with tailored geometries provide a powerful platform for designing and synthesizing polymeric materials with diverse functionalities. This review summarizes recent advances in emulsion-mediated fabrication of block copolymer (BCP) functional colloids and emulsion-templated construction of gel emulsion and porous hydrogels. Key topics include the generation of high-quality, uniform emulsion droplets, control over the shape and internal nanostructure of BCP colloids, and strategies for constructing polymeric gels and other porous functional materials using gel emulsion as templates. Furthermore, the intrinsic properties of polymers can be pre-engineered with specific stimulus-responsive functionalities prior to the fabrication of polymeric microparticles or porous hydrogels, thus imparting novel and targeted functionalities to the resulting assemblies and porous networks. This study can help in developing crucial strategies and in identifying pathways for the rational design of novel multifunctional materials with applications in drug delivery, sensing, and catalysis. Full article

Bacterial vaginosis (BV) is a highly prevalent vaginal infection characterized by a dysbiotic shift in the vaginal microbiota, with Gardnerella vaginalis acting as a principal pathogen. Despite its association with adverse reproductive outcomes, BV remains underexplored from both mechanistic and therapeutic standpoints. Standard antibiotic regimens frequently fail due to high recurrence rates driven by multidrug-resistant (MDR) G. vaginalis strains and biofilm formation. In response, natural compounds and nutraceuticals, owing to their intrinsic antibacterial, antibiofilm, and immunomodulatory properties, have emerged as promising candidates for alternative BV therapies. In this paper, we first compile and critically evaluate preclinical and clinical evidence on the efficacy of plant extracts, essential oils (EOs), probiotics, vitamins, proteins, fatty acids, and enzymes against G. vaginalis, emphasizing their mechanistic insights in restoring vaginal microbial balance. Next, we focus on the integration of these bioactive agents into engineered nanosystems, such as lipid-based nanoparticles (LNPs), polymeric carriers, and inorganic nanostructures, to overcome limitations related to solubility, stability, and targeted delivery. Nonetheless, comparative studies, combination therapies, and recent patent developments are discussed to highlight how naturally derived molecules can enhance antimicrobial potency and reduce cytotoxicity. In conclusion, these platforms demonstrate superior in vitro and in vivo efficacy, offering a paradigm shift in the management of BV. Key challenges include scalable manufacturing, regulatory approval, and comprehensive safety assessment. Future research should prioritize standardized nanoparticle (NP) synthesis, detailed pharmacokinetic and toxicity profiling, and well-designed clinical trials to validate nature-inspired, nanoengineered therapies against G. vaginalis-induced BV. Full article

In this study, patch-structured C₈/CHO template microspheres were successfully synthesized through in situ reduction and sol–gel reactions, providing a reusable platform for subsequent modifications. Based on these templates, temperature-responsive PW₁₂O₄₀³⁻-PILs/PNIPAM Janus nanosheets were prepared via sequential Schiff-base coupling and ATRP. Structural characterizations (XRD, SEM, TEM, FTIR, and TGA) confirmed successful functionalization and nanosheet formation. The PNIPAM moiety endowed the nanosheets with temperature responsiveness, while the incorporation of polymerized ionic liquids and phosphotungstate anions further enhanced amphiphilicity and dispersion stability. When applied as particulate emulsifiers in water/toluene systems, the Janus nanosheets formed stable Pickering emulsions at elevated temperatures and underwent reversible emulsification–demulsification upon temperature cycling. These findings demonstrate the potential of PW₁₂O₄₀³⁻-PILs/PNIPAM Janus nanosheets as smart emulsifiers for responsive separation and formulation technologies. Full article

Background: The treatment of wounds remains a significant clinical challenge, particularly in chronic and infected wounds, where delayed healing often results in complications. Recent advances in biomaterials have highlighted the potential of polymer-based scaffolds as promising platforms for wound management due to their ability to mimic the extracellular matrix, support tissue regeneration, and provide a moist environment conducive to healing. Objectives: This review aims to provide a comprehensive overview of the recent progress in the design and application of polymer-based scaffolds loaded with essential oil (EO) components, emphasizing their role in promoting effective wound healing. Methods: Relevant literature on polymeric scaffolds and EO-based bioactive agents was systematically reviewed, focusing on studies that investigated the biological activities, fabrication techniques, and therapeutic performance of EO-loaded scaffolds in wound management. Results: Findings from recent studies indicate that EO components, particularly monoterpenoids such as thymol, carvacrol, and eugenol, exhibit remarkable antimicrobial, anti-inflammatory, antioxidant, and analgesic properties that accelerate wound healing. When incorporated into polymer matrices, these components enhance scaffold biocompatibility, antimicrobial efficacy, and tissue regeneration capacity through synergistic interactions. Conclusions: The integration of essential oil components into polymeric scaffolds represents a promising strategy for developing multifunctional wound dressings. Such systems combine the structural advantages of polymers with the therapeutic benefits of EOs, offering an effective platform for accelerating healing and preventing wound infections. Full article

Effective protein immobilization is a critical step in biosensor development, as it ensures the stability, functionality, and orientation of biomolecules on the sensor surface. Here, we present a novel affinity-based terpolymer coating designed to enhance protein immobilization for biosensor applications. The novelty lies in the incorporation of nitrilotriacetic acid (NTA) ligands directly into the polymeric chains, facilitating histidine-tagged protein oriented binding through a robust metal-chelating interaction. To validate the system, magnetic microbeads coated with the polymer were tested for their ability to bind native and His-tagged proteins. The results demonstrated the superior binding capacity, enhanced stability, and reversibility of the interactions compared to traditional coatings, which immobilize proteins through nucleophile reactions with amine residues. Moreover, enzyme immobilization tests confirmed that the polymer preserves enzymatic activity, highlighting its potential for biosensor applications requiring functional biomolecules. This innovative polymeric coating offers a fast, versatile, and scalable solution for next-generation biosensor platforms, paving the way for improved sensitivity, reliability, and accessibility in diagnostic and analytical technologies. Full article

The exponential increase in environmental pollutants due to industrialization, urbanization, and agricultural intensification has underscored the urgent need for sensitive, selective, and real-time monitoring technologies. Among emerging analytical tools, organic fluorescent sensors have demonstrated exceptional potential for detecting a wide range of pollutants in water, air, and soil, with a limit of detection (LOD) in the pM–µM range. This review critically examines recent advances in organic fluorescent sensors, focusing on their photophysical properties, molecular structures, sensing mechanisms, and environmental applications. Key categories of organic sensors, including small molecules, polymeric materials, and nanoparticle-based systems, are discussed, highlighting their advantages, such as biocompatibility, tunability, and cost-effectiveness. Comparative insights into inorganic fluorescent sensors, including quantum dots, are also provided, emphasizing their superior photostability and wide operating range (in some cases from pg/mL up to mg/mL) but limited biodegradability and higher toxicity. The integration of nanomaterials and microfluidic systems is presented as a promising route for developing portable, on-site sensing platforms. Finally, the review outlines current challenges and future perspectives, suggesting that fluorescent sensors, particularly organic ones, represent a crucial strategy toward sustainable environmental monitoring and pollutant management. Full article

Ozone (O₃) has re-emerged in periodontology for its antimicrobial, oxygenating, and immunomodulatory actions, yet its role in regeneration remains contentious. This narrative review synthesizes current evidence on adjunctive ozone use in periodontal therapy, delineates cellular constraints—especially in periodontal ligament fibroblasts (PDLFs)—and explores mitigation strategies using bioactive compounds and advanced delivery platforms. Two recent meta-analyses indicate that adjunctive ozone with scaling and root planing yields statistically significant reductions in probing depth and gingival inflammation, with no significant effects on bleeding on probing, plaque control, or clinical attachment level; interpretation is limited by heterogeneity of formulations, concentrations, and delivery methods. Mechanistically, ozone imposes a dose-dependent oxidative burden that depletes glutathione and inhibits glutathione peroxidase and superoxide dismutase, precipitating lipid peroxidation, mitochondrial dysfunction, ATP depletion, and PDLF apoptosis. Concurrent activation of NF-κB and upregulation of IL-6/TNF-α, together with matrix metalloproteinase-mediated extracellular matrix degradation and tissue dehydration (notably with gaseous applications), further impairs fibroblast migration, adhesion, and ECM remodeling, constraining regenerative potential. Emerging countermeasures include co-administration of polyphenols (epigallocatechin-3-gallate, resveratrol, curcumin, quercetin), coenzyme Q10, vitamin C, and hyaluronic acid to restore redox balance, stabilize mitochondria, down-modulate inflammatory cascades, and preserve ECM integrity. Nanocarrier-based platforms (nanoemulsions, polymeric nanoparticles, liposomes, hydrogels, bioadhesive films) offer controlled ozone release and co-delivery of protectants, potentially widening the therapeutic window while minimizing cytotoxicity. Overall, current evidence supports ozone as an experimental adjunct rather than a routine regenerative modality. Priority research needs include protocol standardization, dose–response definition, long-term safety, and rigorously powered randomized trials evaluating bioactive-ozone combinations and nanocarrier systems in clinically relevant periodontal endpoints. Full article

The success of mRNA-based SARS-CoV-2 vaccines has been confirmed in both preclinical and clinical settings. However, the development of safe and efficient mRNA vaccine delivery platforms remains challenging. In this report, PBAE-G-B-SS-modified CaO₂ nanofibers and Au@OVA@Cu@Dendrobium huoshanense polysaccharides were employed to establish novel self-assembling polymeric micelles (CaO₂@Au@OVA@Cu@DHPs) capable of serving as both an adjuvant and a delivery system for mRNA vaccines. In vitro, CaO₂@Au@OVA@Cu@DHPs nanoparticles (NPs) were conducive to effective macrophage antigen uptake and efficient antigen processing. In vivo, P-CaO₂@Au@OVA@Cu@DHPs NP administration was associated with a reduction in the ovalbumin (OVA) release rate that was conducive to the sustained induction of long-term immunity and to the production of higher levels of different IgG subtypes, suggesting that these effects were attributable to enhanced antigen uptake by antigen-presenting cells. Overall, these present data highlight the promise of these P-CaO₂@Au@OVA@Cu@DHPs NPs as an effective and safe platform amenable to vaccine delivery through their ability to provide robust adjuvant activity and sustained antigen release capable of eliciting long-term immunological memory while potentiating humoral and cellular immune responses. Full article

Microfluidic methods are powerful platforms for synthesizing advanced functional materials because they allow for precise control of microscale reaction environments. Microfluidics manipulates reactants in lab-on-a-chip systems to enable the fabrication of highly uniform materials with tunable properties, which are crucial for drug delivery, diagnostics, catalysis, and nanomaterial design. This review emphasizes recent progress in microfluidic technologies for synthesizing functional materials, with a focus on polymeric, hydrogel, lipid-based, and inorganic particles. Microfluidics provides exceptional control over the size, morphology, composition, and surface chemistry of materials, thereby enhancing their performance through uniformity, tunability, hierarchical structuring, and on-chip functionalization. Our review provides novel insights by linking material design strategies with fabrication methods tailored to biomedical applications. We also discuss emerging trends, such as AI-driven optimization, automation, and sustainable microfluidic practices, offering a practical and forward-looking perspective. As the field advances toward robust, standardized, and user-friendly platforms, microfluidics has the potential to increase industrial adoption and enable on-demand solutions in nanotechnology and personalized medicine. Full article

Neuromorphic computing, inspired by the human brain’s architecture, offers a transformative approach to overcoming the limitations of traditional von Neumann systems by enabling highly parallel, energy-efficient information processing. Among emerging materials, MXenes—a class of two-dimensional transition metal carbides and nitrides—have garnered significant attention due to their exceptional electrical conductivity, tunable surface chemistry, and mechanical flexibility. This review comprehensively examines recent advancements in MXene-based optoelectronic synapses and neurons, focusing on their structural properties, device architectures, and operational mechanisms. We emphasize synergistic electrical–optical modulation in memristive and transistor-based synaptic devices, enabling improved energy efficiency, multilevel plasticity, and fast response times. In parallel, MXene-enabled optoelectronic neurons demonstrate integrate-and-fire dynamics and spatiotemporal information integration crucial for biologically inspired neural computations. Furthermore, this review explores innovative neuromorphic hardware platforms that leverage multifunctional MXene devices to achieve programmable synaptic–neuronal switching, enhancing computational flexibility and scalability. Despite these promising developments, challenges remain in device stability, reproducibility, and large-scale integration. Addressing these gaps through advanced synthesis, defect engineering, and architectural innovation will be pivotal for realizing practical, low-power optoelectronic neuromorphic systems. This review thus provides a critical roadmap for advancing MXene-based materials and devices toward next-generation intelligent computing and adaptive sensory applications. Full article

Background: Sustained-release (SR) formulations of non-steroidal anti-inflammatory drugs (NSAIDs) aim to prolong therapeutic activity, reduce dosing frequency, and improve patient adherence. However, currently marketed SR NSAIDs exhibit persistent limitations, including incomplete control over release kinetics, high interpatient variability in bioavailability, limited reduction in gastrointestinal adverse effects, and insufficient dose flexibility for individualized therapy. In many cases, conventional excipients and release mechanisms remain predominant, leaving drug-specific physicochemical and pharmacokinetic constraints only partially addressed. These gaps highlight the need for a comprehensive synthesis of recent technological advances to guide the development of more effective, patient-centered delivery systems. Methods: A narrative literature review was conducted using Web of Science and PubMed databases to identify original research articles and comprehensive technological studies on oral SR formulations of NSAIDs and paracetamol published between January 2020 and March 2025. Inclusion criteria focused on preclinical and technological research addressing formulation design, excipient innovations, and manufacturing approaches. Results: Sixty-four studies met the inclusion criteria, encompassing polymeric matrices (31%), lipid-based carriers (18%), microspheres/hydrogel beads/interpenetrating polymer networks (30%), nanostructured systems (11%), and hybrid platforms (10%). The most common strategies involved pH-dependent release, mucoadhesive systems, and floating drug delivery, aiming to optimize release kinetics, minimize mucosal irritation, and sustain therapeutic plasma levels. Advances in manufacturing—such as hot-melt extrusion, 3D printing, electrospinning, and spray drying—enabled enhanced control of drug release profiles, improved stability, and in some cases up to 30–50% prolongation of release time or reduction in Cmax fluctuations compared with conventional formulations. Conclusions: Recent formulation strategies show substantial potential to overcome long-standing limitations of SR NSAID delivery, with expected benefits for patient compliance and quality of life through reduced dosing frequency, better tolerability, and more predictable therapeutic effects. Nevertheless, integration of in vitro performance with pharmacokinetic and clinical safety outcomes remains limited, and the translation to clinical practice is still in its early stages. This review provides a comprehensive overview of current technological trends, identifies persisting gaps, and proposes future research directions to advance SR NSAID systems toward safer, more effective, and patient-focused therapy. Full article

This study reports the synthesis and characterization of well-defined ionic graft conjugates acting as drug delivery systems, based on monomeric ionic units derived from choline methacrylate (TMAMA) biofunctionalized with the anions of ampicillin (AMP) or cloxacillin (CLX). Using the “grafting from” technique with multifunctional macroinitiators, the density of side chains was precisely defined, and the length of side chains was well-controlled during polymerization. The resulting ionic conjugates featured the regulated content of ionic fractions with drug anions reaching up to 55% and drug content up to 48–70% for AMP, 27–65% for CLX, and 47–79% for (CLX + AMP). The drug release behavior was evaluated under physiological conditions using a dialysis method. The ionic conjugates demonstrated release efficiencies of 70–93% for CLX (5–16 µg/mL), 69–98% for AMP (12–13 µg/mL) in single systems, and 61–73% for CLX + AMP (10–15 µg/mL) in dual systems. Additionally, polymer surface properties were evaluated via water contact angle measurements (WCA = 30–54°). In an aqueous solution, the polymer self-assemblies appeared to be nanosized particles (90–360 nm). The results demonstrate that the synthesized TMAMA-based graft copolymers act as effective ionic conjugates and dual drug systems, offering a promising platform for controlled and multi-drug delivery applications. Full article

This study presents a novel strategy for designing photocurable resins tailored for the additive manufacturing of smart thermoset materials. A quaternary formulation was developed by integrating bis(2-methacryloyl)oxyethyl disulfide (DADS) with an epoxy/thiol-ene system (ETES) composed of diglycidyl ether of bisphenol A (EP), pentaerythritol tetrakis(3-mercaptopropionate) (PTMP), and 4,4′-methylenebis(N,N-diallylaniline) (ACA4). This unique combination enables the simultaneous activation of four polymerization mechanisms: radical photopolymerization, thiol-ene coupling, thiol-Michael addition, and anionic ring-opening, within a single resin matrix. A key innovation lies in the exothermic nature of DADS photopolymerization, which initiates and sustains ETES curing at room temperature, enabling 3D printing without thermal assistance. This represents a significant advancement over conventional systems that require elevated temperatures or post-curing steps. The resulting hybrid poly(acrylate–co-ether–co-thioether) network exhibits enhanced mechanical integrity, shape memory behavior, and intrinsic self-healing capabilities. Dynamic Mechanical Analysis revealed a shape fixity and recovery of 93%, while self-healing tests demonstrated a 94% recovery of viscoelastic properties, as evidenced by near-overlapping storage modulus curves compared to a reference sample. This integrated approach broadens the design space for multifunctional photopolymers and establishes a versatile platform for advanced applications in soft robotics, biomedical devices, and sustainable manufacturing. Full article